Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure

E. S. Barrett, K. M. Hoeger, S. Sathyanarayana, D. H. Abbott, Bruce B Redmon, Ruby H Nguyen, S. H. Swan

Research output: Contribution to journalArticle

  • 4 Citations

Abstract

Polycystic ovary syndrome (PCOS) affects ∼7% of reproductive age women. Although its etiology is unknown, in animals, excess prenatal testosterone (T) exposure induces PCOS-like phenotypes. While measuring fetal T in humans is infeasible, demonstrating in utero androgen exposure using a reliable newborn biomarker, anogenital distance (AGD), would provide evidence for a fetal origin of PCOS and potentially identify girls at risk. Using data from a pregnancy cohort (The Infant Development and Environment Study), we tested the novel hypothesis that infant girls born to women with PCOS have longer AGD, suggesting higher fetal T exposure, than girls born to women without PCOS. During pregnancy, women reported whether they ever had a PCOS diagnosis. After birth, infant girls underwent two AGD measurements: anofourchette distance (AGD-AF) and anoclitoral distance (AGD-AC). We fit adjusted linear regression models to examine the association between maternal PCOS and girls' AGD. In total, 300 mother-daughter dyads had complete data and 23 mothers reported PCOS. AGD was longer in the daughters of women with a PCOS diagnosis compared with daughters of women with no diagnosis (AGD-AF: β=1.21, P=0.05; AGD-AC: β=1.05, P=0.18). Results were stronger in analyses limited to term births (AGD-AF: β=1.65, P=0.02; AGD-AC: β=1.43, P=0.09). Our study is the first to examine AGD in offspring of women with PCOS. Our results are consistent with findings that women with PCOS have longer AGD and suggest that during PCOS pregnancies, daughters may experience elevated T exposure. Identifying the underlying causes of PCOS may facilitate early identification and intervention for those at risk.

LanguageEnglish (US)
Pages307-314
Number of pages8
JournalJournal of Developmental Origins of Health and Disease
Volume9
Issue number3
DOIs
StatePublished - Jun 1 2018

Fingerprint

Polycystic Ovary Syndrome
Nuclear Family
Testosterone
Newborn Infant
Mothers
Pregnancy
Linear Models
Term Birth
Child Development
Androgens
Biomarkers

Keywords

  • AGD
  • PCOS
  • fetal programming
  • pregnancy
  • testosterone

PubMed: MeSH publication types

  • Journal Article

Cite this

Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure. / Barrett, E. S.; Hoeger, K. M.; Sathyanarayana, S.; Abbott, D. H.; Redmon, Bruce B; Nguyen, Ruby H; Swan, S. H.

In: Journal of Developmental Origins of Health and Disease, Vol. 9, No. 3, 01.06.2018, p. 307-314.

Research output: Contribution to journalArticle

@article{f9295699961e41f195241e51726d8bea,
title = "Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure",
abstract = "Polycystic ovary syndrome (PCOS) affects ∼7{\%} of reproductive age women. Although its etiology is unknown, in animals, excess prenatal testosterone (T) exposure induces PCOS-like phenotypes. While measuring fetal T in humans is infeasible, demonstrating in utero androgen exposure using a reliable newborn biomarker, anogenital distance (AGD), would provide evidence for a fetal origin of PCOS and potentially identify girls at risk. Using data from a pregnancy cohort (The Infant Development and Environment Study), we tested the novel hypothesis that infant girls born to women with PCOS have longer AGD, suggesting higher fetal T exposure, than girls born to women without PCOS. During pregnancy, women reported whether they ever had a PCOS diagnosis. After birth, infant girls underwent two AGD measurements: anofourchette distance (AGD-AF) and anoclitoral distance (AGD-AC). We fit adjusted linear regression models to examine the association between maternal PCOS and girls' AGD. In total, 300 mother-daughter dyads had complete data and 23 mothers reported PCOS. AGD was longer in the daughters of women with a PCOS diagnosis compared with daughters of women with no diagnosis (AGD-AF: β=1.21, P=0.05; AGD-AC: β=1.05, P=0.18). Results were stronger in analyses limited to term births (AGD-AF: β=1.65, P=0.02; AGD-AC: β=1.43, P=0.09). Our study is the first to examine AGD in offspring of women with PCOS. Our results are consistent with findings that women with PCOS have longer AGD and suggest that during PCOS pregnancies, daughters may experience elevated T exposure. Identifying the underlying causes of PCOS may facilitate early identification and intervention for those at risk.",
keywords = "AGD, PCOS, fetal programming, pregnancy, testosterone",
author = "Barrett, {E. S.} and Hoeger, {K. M.} and S. Sathyanarayana and Abbott, {D. H.} and Redmon, {Bruce B} and Nguyen, {Ruby H} and Swan, {S. H.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1017/S2040174417001118",
language = "English (US)",
volume = "9",
pages = "307--314",
journal = "Journal of Developmental Origins of Health and Disease",
issn = "2040-1744",
publisher = "Cambridge University Press",
number = "3",

}

TY - JOUR

T1 - Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure

AU - Barrett, E. S.

AU - Hoeger, K. M.

AU - Sathyanarayana, S.

AU - Abbott, D. H.

AU - Redmon, Bruce B

AU - Nguyen, Ruby H

AU - Swan, S. H.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Polycystic ovary syndrome (PCOS) affects ∼7% of reproductive age women. Although its etiology is unknown, in animals, excess prenatal testosterone (T) exposure induces PCOS-like phenotypes. While measuring fetal T in humans is infeasible, demonstrating in utero androgen exposure using a reliable newborn biomarker, anogenital distance (AGD), would provide evidence for a fetal origin of PCOS and potentially identify girls at risk. Using data from a pregnancy cohort (The Infant Development and Environment Study), we tested the novel hypothesis that infant girls born to women with PCOS have longer AGD, suggesting higher fetal T exposure, than girls born to women without PCOS. During pregnancy, women reported whether they ever had a PCOS diagnosis. After birth, infant girls underwent two AGD measurements: anofourchette distance (AGD-AF) and anoclitoral distance (AGD-AC). We fit adjusted linear regression models to examine the association between maternal PCOS and girls' AGD. In total, 300 mother-daughter dyads had complete data and 23 mothers reported PCOS. AGD was longer in the daughters of women with a PCOS diagnosis compared with daughters of women with no diagnosis (AGD-AF: β=1.21, P=0.05; AGD-AC: β=1.05, P=0.18). Results were stronger in analyses limited to term births (AGD-AF: β=1.65, P=0.02; AGD-AC: β=1.43, P=0.09). Our study is the first to examine AGD in offspring of women with PCOS. Our results are consistent with findings that women with PCOS have longer AGD and suggest that during PCOS pregnancies, daughters may experience elevated T exposure. Identifying the underlying causes of PCOS may facilitate early identification and intervention for those at risk.

AB - Polycystic ovary syndrome (PCOS) affects ∼7% of reproductive age women. Although its etiology is unknown, in animals, excess prenatal testosterone (T) exposure induces PCOS-like phenotypes. While measuring fetal T in humans is infeasible, demonstrating in utero androgen exposure using a reliable newborn biomarker, anogenital distance (AGD), would provide evidence for a fetal origin of PCOS and potentially identify girls at risk. Using data from a pregnancy cohort (The Infant Development and Environment Study), we tested the novel hypothesis that infant girls born to women with PCOS have longer AGD, suggesting higher fetal T exposure, than girls born to women without PCOS. During pregnancy, women reported whether they ever had a PCOS diagnosis. After birth, infant girls underwent two AGD measurements: anofourchette distance (AGD-AF) and anoclitoral distance (AGD-AC). We fit adjusted linear regression models to examine the association between maternal PCOS and girls' AGD. In total, 300 mother-daughter dyads had complete data and 23 mothers reported PCOS. AGD was longer in the daughters of women with a PCOS diagnosis compared with daughters of women with no diagnosis (AGD-AF: β=1.21, P=0.05; AGD-AC: β=1.05, P=0.18). Results were stronger in analyses limited to term births (AGD-AF: β=1.65, P=0.02; AGD-AC: β=1.43, P=0.09). Our study is the first to examine AGD in offspring of women with PCOS. Our results are consistent with findings that women with PCOS have longer AGD and suggest that during PCOS pregnancies, daughters may experience elevated T exposure. Identifying the underlying causes of PCOS may facilitate early identification and intervention for those at risk.

KW - AGD

KW - PCOS

KW - fetal programming

KW - pregnancy

KW - testosterone

UR - http://www.scopus.com/inward/record.url?scp=85041293924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041293924&partnerID=8YFLogxK

U2 - 10.1017/S2040174417001118

DO - 10.1017/S2040174417001118

M3 - Article

VL - 9

SP - 307

EP - 314

JO - Journal of Developmental Origins of Health and Disease

T2 - Journal of Developmental Origins of Health and Disease

JF - Journal of Developmental Origins of Health and Disease

SN - 2040-1744

IS - 3

ER -